AI Buyer Insights:

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Michelin, an e2open customer evaluated Oracle Transportation Management

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Michelin, an e2open customer evaluated Oracle Transportation Management

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

AIkido Pharma Inc. Tech Stack and Enterprise Applications

AIkido Pharma Inc. AI Development
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Cogia Intelligence Legacy Cogia Biotech ML and Data Science Platforms AI Development n/a 2020 2020
In 2020, AIkido Pharma Inc. engaged Cogia Biotech to accelerate pancreatic ductal adenocarcinoma genetic-marker research in the United States. AIkido Pharma Inc. used Cogia Biotech, an ML and Data Science Platforms application, to assemble and analyze marker and antibody data as part of a focused research collaboration supporting diagnostic and therapeutic discovery. The implementation leveraged Cogia Biotech's Diagnostic Assay and Prognostic Marker Characterization applications to ingest high dimensional molecular and antibody information, orchestrate big-data analytics, and surface candidate marker signatures and marker clusters. Functional capabilities implemented included assay characterization workflows, prognostic marker profiling, and machine learning driven marker clustering and candidate prioritization consistent with ML and Data Science Platforms workflows. Operationally the engagement ran as a research collaboration across AIkido Pharma research teams in the United States, with outputs assembled for downstream diagnostic assay development and therapeutic target validation. The project produced identified candidate markers and marker clusters to support diagnostics and therapeutics, and used assembled marker and antibody information for subsequent development steps.
AIkido Pharma Inc. Collaboration
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Microsoft Legacy Microsoft 365 Collaboration Collaboration n/a 2020 2020
In 2020, AIkido Pharma Inc. deployed Microsoft 365 to provide Collaboration across the organization. The company lists Microsoft 365 usage on its public website, indicating an active tenant and adoption for day to day collaboration. AIkido Pharma Inc. deployed Microsoft 365 for Collaboration to support professional services business functions including client-facing workflows, internal coordination, and administrative operations. Microsoft 365 was configured to deliver core Collaboration capabilities such as Exchange Online for email, Microsoft Teams for chat and meetings, SharePoint Online and OneDrive for document and content management, and Office applications for productivity. The implementation used centralized tenant administration with Azure Active Directory for user provisioning and access control, and governance emphasized tenant level policy for content sharing and collaboration rather than complex multi site networking. Rollout was proportionate to a 20 person firm, focusing on company wide provisioning, secure external collaboration settings, and streamlined user onboarding.
AIkido Pharma Inc. IaaS
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Microsoft Legacy Microsoft Azure Cloud Services Application Hosting and Computing Services IaaS n/a 2020 2020
In 2020 AIkido Pharma Inc. deployed Microsoft Azure Cloud Services to host its public website under the Application Hosting and Computing Services category. The implementation centers on using Microsoft Azure Cloud Services to provide internet-facing web hosting, platform compute, and object storage for site assets, establishing a cloud-hosted web presence for the company. The deployment uses platform-level compute and managed hosting capabilities typical of Application Hosting and Computing Services, including scalable virtual compute for application code, durable object storage for media and documents, and content delivery capabilities for static assets. The configuration is described as web-centric, with secure certificate termination and DNS management handled through the Azure hosting environment, and automated application deployment pipelines and basic operational monitoring applied to support ongoing updates. Operational coverage is focused on the company website and related customer engagement functions, with responsibility concentrated in small team web operations and marketing workflows. Governance practices align with cloud subscription management, access and identity controls, and environment segregation for production and nonproduction content, using Microsoft Azure Cloud Services as the central platform for hosting and application delivery.
Application Hosting and Computing Services IaaS 2020 2020

IT Decision Makers and Key Stakeholders at AIkido Pharma Inc.

First Name Last Name Title Function Department Email Phone
No data found

Apps Being Evaluated by AIkido Pharma Inc. Executives

APPS RUN THE WORLD tracks software evaluation trends across 2 million companies worldwide, including buyer insights from AIkido Pharma Inc. IT executives and key decision makers. As part of ARTW Buyer Intent and technographics insights, these findings provide useful visibility into the AIkido Pharma Inc. digital transformation priorities and AI adoption trends.
Date Company Status Vendor Product Category Market
No data found
FAQ - APPS RUN THE WORLD AIkido Pharma Inc. Technographics
AIkido Pharma Inc. is a Professional Services organization based in United States, with around 20 employees and annual revenues of $2.0 million.
AIkido Pharma Inc. operates a diverse technology stack with applications such as Cogia Biotech, Microsoft 365 and Microsoft Azure Cloud Services, covering areas like ML and Data Science Platforms, Collaboration and Application Hosting and Computing Services.
AIkido Pharma Inc. has invested in cloud applications and AI-driven platforms to optimize efficiency and growth, collaborating with vendors such as Cogia Intelligence and Microsoft.
AIkido Pharma Inc. recently adopted applications including Cogia Biotech in 2020, Microsoft 365 in 2020 and Microsoft Azure Cloud Services in 2020, highlighting its ongoing modernization strategy.
APPS RUN THE WORLD maintains an up-to-date database of AIkido Pharma Inc.’s key decision makers and IT executives, available to Premium subscribers.
Our research team continuously updates AIkido Pharma Inc.’s profile with verified software purchases, vendor relationships, and digital initiatives identified from public and proprietary sources.
Subscribe to APPS RUN THE WORLD to access the complete AIkido Pharma Inc. technographics profile, including detailed breakdowns by category, vendor, and IT decision makers.